SBRT2015

Priority areas for research

PATIENT'SELECTION'

◦

If$a$RCT$is$not$feasible$in$medically$operable$ES9NSCLC$patients,$investigate$the$

role$of$SABR$through$CER$using$detailed$prospective$registration$of$comorbidity$

and$toxicity$data$

◦

Establish$the$risks$and$benefits$of$SABR$in$CT9screened$ES9NSCLC$lung$cancer$

patients$

◦

Develop$robust$prediction$models$for$distant$metastasis$risk$in$order$to$guide$

adjuvant$treatment$

◦

Establish$the$safety$and$appropriate$administration$of$adjuvant$systemic$therapy$

◦

Identify$patients$in$whom$SABR$should$not$be$offered,$due$to$high$risk$of$early$

mortality$from$competing$causes$

Louie AV, Radioth Oncol 2015